Safety Alert for MedNet Medication Management Suite

According to Department of Health, this safety alert involved a device in Hong Kong that was produced by Hospira.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Date
    2017-10-25
  • Event Date Posted
    2017-10-25
  • Event Country
  • Event Source
    DH
  • Event Source URL
  • Notes / Alerts
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
    ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
  • Extra notes in the data
    Medical Device Safety Alert
  • Reason
    Medical device safety alert: hospira mednet medication management suite the therapeutic goods administration (tga) of australia has posted a medical device safety alert concerning hospira labelled mednet medication management suite – with plum 360 infusion system [(i) version 6.1; list number: 16037-75-01; (ii) version 6.21; list number: 16037-75-02], manufactured by hospira (now icu medical). the manufacturer has identified issues with hospira labelled mednet medication management suite versions 6.1 and 6.21 when used with plum 360 drug library management that occur during an import of a plum 360 drug library. the mednet meds 6.1 and 6.21 programs, under certain conditions, can change the piggyback medication entry set settings for existing defined medication entries. this includes (a) whether a medication may be piggybacked and (b) whether an infusion may be interrupted by a piggyback. a change to a piggyback rule set could result in a delay initiating a therapy or interruption of an active infusion. this issue could also lead to mixing of two infusion solutions. if two mixed solutions are incompatible a particulate could result or, if during a transfusion, a blood clot could form in the administration set. in rare circumstances, these conditions could lead to serious adverse health consequences. the manufacturer is advising users that the issue arises during an import of a plum 360 drug library. users who have performed an import of a plum 360 drug library or have the need to do so should refer to the information provided to customers to confirm if the drug library is affected during the import. a correction to the issues will be addressed in mednet version 6.3. for details, please refer to the tga website: http://apps.Tga.Gov.Au/prod/sara/arn-detail.Aspx?k=rc-2017-rn-01336-1 if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 25 october 2017.

Device

  • Model / Serial
  • Product Description
    Medical Device Safety Alert: Hospira MedNet Medication Management Suite
  • Manufacturer

Manufacturer

  • Manufacturer Parent Company (2017)
  • Source
    DH